Specialty Enzymes Market Key Players : Novozymes, DuPont, F. Hoffmann-La Roche AG, BASF, Life technologies, Advance enzyme Technologies Ltd, Affymetrix, Inc., and Codexis, Inc.

Specialty enzymes have gained popularity in the recent years owing to their potential applications in various industries such as pharmaceutical, biotechnology research and diagnostics. Specialty enzymes are proteins that act as biocatalysts to accelerate reactions and produce the desired results in pharmaceuticals and diagnostics reactions. In the pharmaceuticals industry, specialty enzymes play a major role in drug formulation and drug delivery. Enzyme based pharmaceutical drug formulations are used for the treatment of chronic conditions such as cancer and AIDS.

Specialty enzymes have been widely used in the biotechnology industry for research, particularly in the molecular biology. They are also used in genetic engineering techniques to cut, replicate and attach DNA as per requirement. Specialty enzymes play a major role in the diagnosis of diseases such as cancer, cardiovascular diseases and lysosomal disorders. The specialty enzymes required for diagnostics has to be of the highest purity and in small quantity, which results in the high cost and less adoption of diagnostic enzymes.

Geographically, the specialty enzyme market is segmented into North America, Europe, Asia-Pacific and LAMEA regions. North America region had the largest market for the specialty enzymes in 2014 due to the presence of large number of biopharmaceutical companies in the U.S. and favorable government regulations. High prevalence rates of digestive disorders would also fuel the demand for the digestive aids and supplements in the North America specialty enzymes market. The key companies profiled in this report include, Novozymes, DuPont, F. Hoffmann-La Roche AG, BASF, Life technologies, Advance enzyme Technologies Ltd, Affymetrix, Inc., and Codexis, Inc.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-sample/703

The increasing applications of enzymes in therapies for chronic diseases, rising demand for effective therapeutics and growing incidences of digestive enzyme disorders are some of the key factors that drive the growth of the global specialty enzymes market for pharmaceuticals, biotechnology research and diagnostics. Factors restraining the market growth are restriction concerning the chemical properties and safety issues arising due to the contamination of enzymes. The global specialty enzymes market for pharmaceuticals, biotechnology research and diagnostics accounted for $561.9 million in 2014 and is forecast to generate $947.5 million by 2020, registering a CAGR of 9.4% during 2015 - 2020.

The global specialty enzymes for pharmaceuticals, biotechnology R&D and diagnostics market is segmented based on the application, source, type and geography. Based on the applications, the market is segmented into pharmaceuticals, biotechnology R&D and diagnostics. Based on the source, the market is segmented into three types, namely microorganisms, plants and animals. The microorganisms segment held a dominant share in the market in 2014 owing to its easy availability, feasibility for large scale production and cost-effectiveness. Microorganisms are easier to cultivate and the quantity of enzyme production can be controlled and estimated. Based on the product type, the market is segmented into acylases, hydratases, humulin, oxidase, lyases, restriction enzymes, ligases, polymerases, lipases, amylases, proteases, dehydrogenases, glucuronidase and others. Acylases enzyme held a dominant share of the market in 2014 owing to its wide and diversified application in the pharmaceutical drug formulations.
Key Market Benefits:

• The report provides a quantitative analysis of the current market estimations during the period of 2014 - 2020, which would enable the stakeholders to capitalize on prevailing market opportunities
• Extensive analysis of the global specialty enzymes market by type helps in understanding the types of enzymes that are currently used along with the variants that would gain prominence in future
• Competitive intelligence highlights the business practices followed by leading market players across various geographies
• Comprehensive analysis of factors that drive and restrict the growth of the global specialty enzymes market has been provided
• SWOT analysis highlights the internal environment of leading companies for effective strategy formulation
• The specialty enzymes market scenario has been comprehensively analyzed in accordance to the key regions

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.